• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

    11/7/25 8:45:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care
    Get the next $BAX alert in real time by email
    • Funding from the Baxter Foundation builds on 15+ year partnership with Northwestern University's School of Education and Social Policy to promote engagement and confidence in Science, Technology, Engineering and Mathematics (STEM) for Chicagoland youth and professional development opportunities for Chicagoland teachers
    • Three-year funding will support continuation and evolution of existing Baxter Center for Science Education programs
    • New grant announcement coincides with National STEM Day to drive greater awareness of the need to collectively support the next generation of innovators

    The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the continuation of a partnership with Northwestern University's School of Education and Social Policy (SESP) to provide science, technology, engineering and math (STEM) programs for students and teachers throughout the Chicagoland area. Supported by a three-year $2.6 million grant from the Foundation, the Baxter Center for Science Education (BCSE) – an affiliated center with Northwestern University's SESP – will continue to help elevate educators through cutting-edge science, support classrooms through lab supplies and equipment, and engage students in STEM experiences to support and expand potential career pathways.

    "Our partnership with Northwestern University to advance STEM education through the Baxter Center for Science Education is part of the Baxter Foundation's longstanding commitment to developing the next generation of innovators," said Verónica Arroyave, Ph.D., vice president of corporate responsibility and global philanthropy at Baxter and executive director of the Baxter Foundation. "We're proud to help the Baxter Center for Science Education continue its work to positively impact the development of our future scientists, engineers, researchers, healthcare providers and more."

    The BCSE was founded in 2009 with an initial grant from the Foundation and today operates as a partnership between the SESP at Northwestern University, Lindblom Math and Science Academy in Chicago, Round Lake Area Schools and the Baxter Foundation. Since its founding, the Foundation has now provided nearly $9 million in funding to support meaningful programming. During that time, the BCSE has reached approximately 260,000 students and trained nearly 4,000 teachers across more than 400 schools in Cook and Lake counties. Program highlights include:

    • Elevating educators: Innovative professional development opportunities – such as an immersive research experience program, free workshops that are eligible for professional development hours with the Illinois State Board of Education and an annual symposium – offer Chicagoland educators hands-on experiences, real-life laboratory practice and collaborative settings to inspire ongoing excellence in STEM education delivery.
    • Supporting classrooms: To help ensure educators have the supplies they need to create meaningful STEM lessons for their students, initiatives like the Baxter Box program – which offers teachers the ability to borrow materials and equipment for biology and biotechnology labs for free – and Lab Grants – which fund requests for lab equipment and supplies, from lab coats and goggles to blood typing kits, pipettes, incubators and more – are signature to the BCSE's work.
    • Engaging students, partner schools and local communities: Dynamic partnerships with schools, districts and other community organizations help to engage students in valuable STEM experiences that connect directly to future academic and career pathways. Partner schools both design and participate in impactful learning opportunities, such as field trips to Northwestern University's Feinberg School of Medicine. These experiences are enriched by near-peer mentoring, where students engage with undergraduates working in STEM fields, fostering inspiration and insight into potential career journeys. The BCSE is continuously assessing and adapting opportunities to expand and better meet community needs and opportunities.

    "Teachers often share with us how highly they value BCSE experiences and resources. When teachers can learn alongside each other during events led by teacher leaders, it empowers them to share that joy and learning in their own classrooms – to students' benefit," said Jen Lewin, director of the BCSE. "As we celebrate and recognize National STEM Day, we thank the Baxter Foundation for the support to sustain this work, which prioritizes listening to what our communities are asking for."

    Access to robust STEM training and materials is crucial, particularly in settings with limited resources. Programming offered by the BCSE, with support from the Baxter Foundation, helps ensure that teachers stay up to date on STEM trends and teachings while students get exposure to interesting and interactive lessons to inspire the next generation of innovators.

    About the Baxter Foundation

    Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and to create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page.

    About Northwestern University's School of Education and Social Policy and the Baxter Center for Science Education

    The interdisciplinary School of Education and Social Policy (SESP) explores how people learn, grow, and develop throughout life. We study this across different ages, settings, and scales—in both policy and practice. Our mission is to understand and support human wellbeing, helping individuals, communities, and places thrive. SESP catalyzes change by connecting a range of disciplines – including psychology, economics, computer science, organizational studies, political science, sociology, and education.

    The Baxter Center for Science Education (BCSE) is a collaborative partnership between the School of Education and Social Policy (SESP) at Northwestern University, Lindblom Math and Science Academy, Round Lake Area Schools, and the Baxter Foundation, with evolving and responsive expansions to our broader communities of Cook and Lake Counties. The BCSE helps to provide impactful educator professional development programs, support meaningful classroom and student STEM experiences, and catalyze mutually beneficial collaborations within the STEM education ecosystem of Chicagoland. Through these initiatives, the BCSE seeks to promote engagement and confidence in STEM among Chicagoland youth and teachers, and leadership opportunities among Chicagoland teachers.

    Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251107310329/en/

    Media Contact

    Tara Reardon, (224) 948-5353

    [email protected]

    Get the next $BAX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BAX

    DatePrice TargetRatingAnalyst
    10/31/2025Buy → Hold
    Argus
    8/4/2025$25.00Buy → Hold
    Stifel
    8/1/2025$25.00Buy → Neutral
    Goldman
    2/26/2025$42.00Buy
    Goldman
    2/24/2025Hold → Buy
    Argus
    2/20/2025$39.00Overweight
    Barclays
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    5/30/2024$36.00Neutral
    Goldman
    More analyst ratings

    $BAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

    Funding from the Baxter Foundation builds on 15+ year partnership with Northwestern University's School of Education and Social Policy to promote engagement and confidence in Science, Technology, Engineering and Mathematics (STEM) for Chicagoland youth and professional development opportunities for Chicagoland teachers Three-year funding will support continuation and evolution of existing Baxter Center for Science Education programs New grant announcement coincides with National STEM Day to drive greater awareness of the need to collectively support the next generation of innovators The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech

    11/7/25 8:45:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Reports Third-Quarter 2025 Results

    Third-quarter sales from continuing operations of $2.84 billion increased 5% on a reported basis and 2% on an operational basis1,2 Third-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.10); adjusted diluted EPS from continuing operations of $0.69 Andrew Hider joined the company as president and chief executive officer (CEO), now leading the company's focus to drive continuous improvement and sustainable growth and create shareholder value Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025. "I joined Baxter because it's a global healthcare leader – an iconic brand with an

    10/30/25 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors

    Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywh

    10/15/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP,Group President,Pharma Sonig Alok covered exercise/tax liability with 3,191 shares, decreasing direct ownership by 2% to 128,219 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    9/4/25 6:02:32 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    President and CEO Hider Andrew P. was granted 368,050 shares (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    9/4/25 6:01:54 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    EVP and CFO Grade Joel T. was granted 102,712 shares, increasing direct ownership by 86% to 222,560 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    9/4/25 6:01:18 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    SEC Filings

    View All

    SEC Form 10-Q filed by Baxter International Inc.

    10-Q - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    11/4/25 4:35:32 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    10/30/25 7:17:52 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter International Inc. filed SEC Form 8-K: Leadership Update

    8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    10/21/25 9:00:55 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Baxter downgraded by Argus

    Argus downgraded Baxter from Buy to Hold

    10/31/25 8:47:22 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Stifel with a new price target

    Stifel downgraded Baxter from Buy to Hold and set a new price target of $25.00

    8/4/25 8:18:58 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter downgraded by Goldman with a new price target

    Goldman downgraded Baxter from Buy to Neutral and set a new price target of $25.00

    8/1/25 8:11:11 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Baxter International Inc.

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    11/13/24 1:08:27 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Baxter International Inc. (Amendment)

    SC 13G/A - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 5:00:53 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Baxter International Inc.

    SC 13G - BAXTER INTERNATIONAL INC (0000010456) (Subject)

    2/13/24 1:08:57 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Financials

    Live finance-specific insights

    View All

    Baxter Reports Third-Quarter 2025 Results

    Third-quarter sales from continuing operations of $2.84 billion increased 5% on a reported basis and 2% on an operational basis1,2 Third-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.10); adjusted diluted EPS from continuing operations of $0.69 Andrew Hider joined the company as president and chief executive officer (CEO), now leading the company's focus to drive continuous improvement and sustainable growth and create shareholder value Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2025. "I joined Baxter because it's a global healthcare leader – an iconic brand with an

    10/30/25 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter to Host Third-Quarter 2025 Financial Results Conference Call for Investors

    Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its third-quarter 2025 financial results on Thursday, October 30, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156235 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywh

    10/15/25 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Baxter Reports Second-Quarter 2025 Results

    Second-quarter sales from continuing operations of $2.81 billion increased 4% on a reported basis and 1% on an operational basis, in line with the company's previously issued guidance1,2 Second-quarter U.S. GAAP3 diluted earnings per share (EPS) from continuing operations of $0.24; adjusted diluted EPS from continuing operations of $0.59, in line with the company's previously issued guidance Recently announced appointment of Andrew Hider as president and chief executive officer (CEO)4 supports company's focus to accelerate innovation, drive sustainable growth, enhance operational effectiveness and create shareholder value Baxter International Inc. (NYSE:BAX), a global medtech lead

    7/31/25 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $BAX
    Leadership Updates

    Live Leadership Updates

    View All

    Baxter Appoints Andrew Hider Chief Executive Officer

    Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

    7/7/25 8:35:00 AM ET
    $ATS
    $BAX
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Amerant Bancorp Announces Appointment of Two New Board Members

    Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

    6/24/25 9:20:00 AM ET
    $AMTB
    $BAX
    $WBS
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care

    PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

    Former Baxter and Baxalta Chief Financial Officer brings more than 30 years of biotech financial and operational experience PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert "Bob" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthca

    3/11/25 7:05:00 AM ET
    $BAX
    $BMRN
    $EMBC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Medical Specialities